Cargando…

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency

Both the presence of latently infected cells and cell-to-cell viral transmission are means whereby HIV can partially evade the inhibitory activities of antiretroviral drugs. The clinical use of a novel integrase inhibitor, dolutegravir (DTG), has established hope that this compound may limit HIV per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastarache, Sophie M., Mesplède, Thibault, Donahue, Daniel A., Sloan, Richard D., Wainberg, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189035/ https://www.ncbi.nlm.nih.gov/pubmed/25243372 http://dx.doi.org/10.3390/v6093487

Ejemplares similares

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
por: Donahue, Daniel A, et al.
Publicado: (2013)

Latent HIV-1 can be reactivated by superinfection in a Tat-dependent manner, which can lead to the emergence of recombinant viruses
por: Donahue, Daniel Aaron, et al.
Publicado: (2013)

Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
por: Mesplède, Thibault, et al.
Publicado: (2015)

Will LEDGIN molecules be able to play a role in a cure for HIV infection?
por: Mesplède, Thibault, et al.
Publicado: (2016)

Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
por: Wainberg, Mark A, et al.
Publicado: (2015)

Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1
por: Kuhl, BD, et al.
Publicado: (2010)

Cell-to-cell transmission of HIV-1 between CD4(+)T-cells involves clathrin-mediated endocytosis
por: Sloan, Richard D, et al.
Publicado: (2011)

What if HIV were unable to develop resistance against a new therapeutic agent?
por: Wainberg, Mark A, et al.
Publicado: (2013)

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses
por: Pham, Hanh T., et al.
Publicado: (2016)

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?
por: Mesplède, Thibault, et al.
Publicado: (2014)

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review
por: Hassounah, Said A., et al.
Publicado: (2016)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness
por: Wares, Melissa, et al.
Publicado: (2014)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
por: Mesplède, Thibault, et al.
Publicado: (2013)

Establishment of an In Vitro Model of Pseudorabies Virus Latency and Reactivation and Identification of Key Viral Latency-Associated Genes
por: Pan, Li, et al.
Publicado: (2023)

Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maraviroc
por: Kramer, Victor, et al.
Publicado: (2014)

Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor
por: Quashie, Peter K., et al.
Publicado: (2015)

Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency
por: Thellman, Nikki M., et al.
Publicado: (2017)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

Strength of T cell signaling regulates HIV-1 replication and establishment of latency
por: Gagne, Matthew, et al.
Publicado: (2019)

HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group M
por: Depatureaux, Agnès, et al.
Publicado: (2014)

Epigenetic Heterogeneity in HIV-1 Latency Establishment
por: Matsuda, Yuka, et al.
Publicado: (2015)

Tetherin restricts direct cell-to-cell infection of HIV-1
por: Kuhl, Björn D, et al.
Publicado: (2010)

Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient In Vivo Reactivation
por: Ramakrishna, Chandran, et al.
Publicado: (2015)

T Cells and the Regulation of Herpes Simplex Virus Latency and Reactivation
por: Nash, Anthony A.
Publicado: (2000)

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
por: Mesplède, Thibault, et al.
Publicado: (2017)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study
por: Palanisamy, Navaneethan, et al.
Publicado: (2017)

Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity
por: Singhroy, Diane N, et al.
Publicado: (2013)

Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration”
por: Mesplède, Thibault, et al.
Publicado: (2018)

Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro
por: Anderson, Jenny L., et al.
Publicado: (2016)

Experimental Systems for Measuring HIV Latency and Reactivation
por: Fujinaga, Koh, et al.
Publicado: (2020)

Inhibition of NF-κB Activation In Vivo Impairs Establishment of Gammaherpesvirus Latency
por: Krug, Laurie T, et al.
Publicado: (2007)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

B cell activation and the establishment of Epstein-Barr virus latency
Publicado: (1988)

Modulation of host cell signaling during cytomegalovirus latency and reactivation
por: Smith, Nicholas A., et al.
Publicado: (2021)

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes
por: Sloan, Richard D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cd7s237vutorvsg5ev180hhrcq